The global aspirin enteric coated tablets market is anticipated to grow at a significant CAGR during the forecast period (2022-2028). Enteric-coated aspirin can also be labelled ‘safety coated’, and describes a coating on the tablets that allow them to pass from the stomach to the intestine before dissolving. These tablets do not include those that are simply coated for ease of swallowing, however, actively prevent the tablet from dissolving in the stomach. This action is mainly to do with preventing issues surrounding stomach discomfort caused by aspirin to some people.
The versatility of Aspirin is expected to provide significant thrust the market growth during the forecast period. Common applications of Aspirin include reducing fever, as a pain reliever, anti-inflammatory drug, and is also used as a blood thinner. The drug is available in the form of prescription aspirin or non-prescription or OTC aspirin across the globe. In some cases, Aspirin is used as one of the additives in the development of specific healthcare products such as hydrogels by Cardinal Health. Such product formation incorporating aspirin as one of their ingredients are also contributing to driving the market growth. Some key players operating in the market include Bayer AG, and GlaxoSmithKline plc, among others. These players are eyeing on strengthening their position in the market by adopting various strategies such as mergers and acquisitions, partnerships and collaborations, new product launches and development in the existing product portfolio, and so on.
Market Coverage
Segment Covered-
Regions covered-
Competitive Landscape: Bayer AG, and GlaxoSmithKline plc, among others.
Key questions addressed by the report
o Deviation from the pre-COVID-19 forecast
o Most affected region and segment
Global Aspirin Enteric Coated Tablets Market Report by Segment
By Application
By Type
Global Aspirin Enteric-Coated Tablets Market Report by Region
North America
Europe
Asia-Pacific
Rest of the World